More tools:Markets·Screener·Research·Chat

Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH) Financial Statements

Shuttle Pharmaceuticals Holdings, Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG017Z2NGC6
XNAS · usd
3.54▲ 0.04 (1.14%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value—
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt—
Trading Information
Previous Close3.50
Day's Range3.42 – 3.61
52-Week Range0.38 – 6.15
Volume10.7K
Avg Volume202.1K
Share Statistics
Shares Outstanding
Employees2
ExchangeXNAS
Listed2022-08-31
Share count as of March 24, 2026
Loading Income Statement…
Key questions about Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH)
What is Shuttle Pharmaceuticals Holdings, Inc. Common Stock's Market Cap?
Shuttle Pharmaceuticals Holdings, Inc. Common Stock's Market Cap is $19.8M, based on as-reported figures from SEC (XBRL) filings.
What is Shuttle Pharmaceuticals Holdings, Inc. Common Stock's Revenue (TTM)?
Shuttle Pharmaceuticals Holdings, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Shuttle Pharmaceuticals Holdings, Inc. Common Stock's Net Income (TTM)?
Shuttle Pharmaceuticals Holdings, Inc. Common Stock's Net Income (TTM) is -$11.7M, based on as-reported figures from SEC (XBRL) filings.
What is Shuttle Pharmaceuticals Holdings, Inc. Common Stock's EBITDA?
Shuttle Pharmaceuticals Holdings, Inc. Common Stock's EBITDA is -$11.6M, based on as-reported figures from SEC (XBRL) filings.
What is Shuttle Pharmaceuticals Holdings, Inc. Common Stock's Diluted EPS (TTM)?
Shuttle Pharmaceuticals Holdings, Inc. Common Stock's Diluted EPS (TTM) is -2.10, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022
Operating expenses
Research and Development Expense
Selling, General and Administrative Expense
Placement agent fees, legal costs and other expenses
Total operating expenses
Net loss from operations
Net loss
Earnings Per Share (Basic)
Earnings Per Share (Diluted)